Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with infliximab.

Fabre, S; Gibert, C; Lechiche, C; Dereure, J; Jorgensen, C; Sany, J

Fabre, S; Gibert, C; Lechiche, C; Dereure, J; Jorgensen, C; Sany, J.

Affiliation

Fabre S; Department of Immuno-Rheumatology, CHU Lapeyronie, 371 av Doyen Gaston Giraud, 34090 Montpellier, France. s-fabre@chu-montpellier.fr

Clin Exp Rheumatol ; 23(6): 891-2, 2005.

Article in En | MEDLINE | ID: mdl-16396712

Subject(s)

Antibodies, Monoclonal/adverse effects; Antirheumatic Agents/administration & dosage; Arthritis, Rheumatoid/drug therapy; Leishmaniasis, Visceral/complications; Opportunistic Infections/parasitology; Arthritis, Rheumatoid/complications; Female; Humans; Infliximab; Leishmaniasis, Visceral/immunology; Middle Aged; Opportunistic Infections/immunology; Tumor Necrosis Factor-alpha/antagonists & inhibitors

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Arthritis, Rheumatoid / Opportunistic Infections / Antirheumatic Agents / Leishmaniasis, Visceral / Antibodies, Monoclonal Limits: Female / Humans / Middle aged Language: En Year: 2005 Type: Article

Search on Google

XML

PubMed Links